Efficacy of Torque Teno Virus as a Biomarker for Predicting Treatment Response of Immune Checkpoint Inhibitor Therapy and Postoperative Outcome in NSCLC Patients

NCT06967532 · clinicaltrials.gov ↗

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

NSCLC (Non-small Cell Lung Cancer)

Interventions

DIAGNOSTIC_TEST: Blood test

Sponsor

Medical University of Vienna